Commerzbank Aktiengesellschaft’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,658	Closed	-$4K	–	1046
2016 Q3	$4K	Hold	10,658	–	–	﹤0.01%	910
2016 Q2	$5	Buy	+10,658	New	+$5	﹤0.01%	987
2013 Q4	–	Sell	-15,300	Closed	-$35K	–	1468
2013 Q3	$35K	Buy	+15,300	New	+$35K	﹤0.01%	1281

Commerzbank Aktiengesellschaft's RXII Position: Q4 2016 in Review

Commerzbank Aktiengesellschaft sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 10,658 shares — an estimated $4K sold.

Commerzbank Aktiengesellschaft first reported a position in RXII in Q3 2013 and held it in 3 quarters. The position peaked at $35K in Q3 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Commerzbank Aktiengesellschaft reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 10,658 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
Commerzbank Aktiengesellschaft first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 3 quarters.
Commerzbank Aktiengesellschaft's GALENA BIOPHARMA INC COM position peaked at $35K in Q3 2013.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2016, filed 7 Feb 2017.